beijing to build a microbial strain bank with a storage capacity of 100,000 strains
2024-09-19
한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina
original title: the city will form 1 to 2 billion-level synthetic biology manufacturing industry clusters within three years
beijing to build a microbial strain bank with a storage capacity of 100,000 strains
by 2026, beijing will establish a microbial strain collection with a storage capacity of more than 100,000 strains, add about 10,000 patented strains, add three synthetic biology manufacturing listed companies, and initially form one to two 10 billion-level industrial clusters. recently, the beijing municipal science and technology commission, zhongguancun management committee, the municipal development and reform commission, and the municipal bureau of economics and information technology jointly issued the "beijing action plan for accelerating the innovation and development of synthetic biology manufacturing industry (2024-2026)" to accelerate the layout of the city's synthetic biology manufacturing industry.
at present, cutting-edge biotechnologies such as gene editing and gene sequencing are accelerating breakthroughs, and biomanufacturing based on synthetic biology has become one of the commanding heights of global science and technology and industrial competition. the development of beijing's synthetic biology manufacturing industry has three superimposed advantages: outstanding original research capabilities, strong demand for low-carbon transformation, and clear pioneering demonstration orientation. it is at a critical stage of transition from the introduction period to the growth period. the development of the synthetic biology manufacturing industry is an important direction for the city to seize the opportunities of the global bioeconomic development and accelerate the formation of new quality productivity.
the development goals proposed in the action plan are: by 2026, beijing's synthetic biology manufacturing's innovative resource aggregation, industrial innovation source, demonstration application leadership, and regional radiation driving force will be comprehensively improved, and a development pattern of beijing's innovation source, tianjin and hebei's support, and radiation driving the whole country will be basically formed; a number of major original achievements will be produced, a number of core key technologies urgently needed by the industry will be broken through, and no less than 5 leading teams in synthetic biology will be introduced and cultivated to create an original innovation source for synthetic biology manufacturing with international influence, and the independent innovation capability will be significantly improved; a microbial strain collection with a storage capacity of more than 100,000 strains will be established, and about 10,000 new patented strains will be added. no less than 2 synthetic biology manufacturing design and automatic control platforms and 3-5 1,000-liter pilot process expansion platforms will be deployed, and the industrial support system will be continuously optimized; a number of innovative products will be launched in key application areas, 3 new synthetic biology manufacturing listed companies will be added, 5-10 leading companies with domestic and international influence will be introduced and cultivated, more than 100 outstanding start-up hard technology companies will be cultivated, and 1-2 10 billion-level industrial agglomeration areas will be initially formed, and the bio-economic growth pole will be accelerated.
to this end, the "several measures for beijing to accelerate the innovation and development of synthetic biology manufacturing industry" was also issued, which identified a series of key tasks. specifically, it includes strengthening and improving original innovation capabilities, guiding major scientific research infrastructure and high-end scientific research instruments in beijing to open up to scientific research activities in the field of synthetic biology manufacturing, and providing testing, detection, research and development services for enterprises with a maximum of no more than 1 million yuan in financial support; supporting the construction of common technology platforms, providing common technology research and development and application services for industrial needs, and providing a maximum of no more than 50 million yuan in support; supporting qualified high-tech enterprises to "build foundations and expand capacity" and "small-scale to large-scale" cultivation, and providing a one-time research and development fund support of no more than 100,000 yuan for the first growth into a national high-tech enterprise; supporting the transformation and upgrading of stock space for the development of synthetic biology manufacturing industry, and providing no more than 10 million yuan in financial support for 30% of the actual investment in project transformation for qualified related enterprises approved for listing on the new third board; establishing a shared enterprise demand library and scientific and technological achievement library for beijing, tianjin and hebei, selecting a number of urgent and implementation-based technology (product) research directions, and promoting joint research and industrialization support, etc.
